CHMP issues positive opinion on abiraterone acetate to include earlier prostate cancer

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended broadening the existing marketing authorisation for abiraterone acetate plus prednisone / prednisolone to include an earlier stage of prostate...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2yJkhnp
via IFTTT